Can Elderly Patients With DLBCL Tolerate Standard Treatment?

The OS benefit associated with standard treatment diminished in patients older than 80 with high comorbidity scores, but other age groups fared better.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news